Thank you for these great comments about survivorship plans. In looking at this issue, we recognize that many of the issues that IO-treated patients with melanoma face long-term differ from those, say for a patient with breast cancer who has received chemotherapy. If you could modify these boilerplate templates for your patients living with melanoma (ie, perhaps a better term than survivors), what would you include?
